Currently predicting for Thu, 2 May 2024

Trading levels for CLSD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.36 7.94 %
R2 1.33 5.51 %
R1 1.31 4.01 %
Current price: 1.26
Support S1 1.25 -0.84 %
S2 1.23 -2.34 %
S3 1.20 -4.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.56 23.81 %
R2 1.51 19.84 %
R1 1.29 2.38 %
Current price 1.26
Support S1 1.25 -0.794%
S2 1.23 -2.38%
S3 1.15 -8.73%

CLSD Predictions History

4 years ago
JS predicted that CLSD for 2019-12-30 is going $3.00 (-3.85%)

4 years ago
Alan predicted that CLSD for 2019-12-30 is going $3.03 (-3.50%)

4 years ago
2poJeff predicted that CLSD for 2019-12-24 is going $2.55 (-5.38%)

4 years ago
Joe130443 predicted that CLSD for 2019-12-24 is going

Rank:

4 years ago
Joe130443 predicted that CLSD for 2019-12-23 is going

Rank:

4 years ago
PumpTheseNumbers predicted that CLSD for 2019-12-12 is going $1.72 (-0.58%)

4 years ago
Alan predicted that CLSD for 2019-12-12 is going $1.85 (6.94%)

4 years ago
Alan predicted that CLSD for 2019-11-26 is going $1.36 (6.25%)

4 years ago
Adam Cutter predicted that CLSD for 2019-11-05 is going

Rank:

4 years ago
NameNotImportant predicted that CLSD for 2019-05-06 is going $1.25 (0.81%)

Click to get the best stock tips daily for free!

About Clearside BioMedical, Inc

Clearside BioMedical Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i... CLSD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT